miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling
Recombinant tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), as a novel cancer therapeutic, is being tested in phase II and III clinical trials; however, TRAIL resistance remains a big obstacle preventing its clinical application. Considering that TRAIL-induced apoptosis throug...
Saved in:
Main Authors: | Shan-shan Wang (Author), Lu Feng (Author), Bao-guang Hu (Author), Ying-fei Lu (Author), Wei-mao Wang (Author), Wei Guo (Author), Chun-wai Suen (Author), Bao-hua Jiao (Author), Jian-xin Pang (Author), Wei-ming Fu (Author), Jin-fang Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NF-κB-Regulated miR-99a Modulates Endothelial Cell Inflammation
by: Mei-hua Bao, et al.
Published: (2016) -
Parthenolide Induces Apoptosis in Glioblastomas Without Affecting NF-κ B
by: Krystal N. Anderson, et al.
Published: (2008) -
Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
by: Md. Sahab Uddin, et al.
Published: (2021) -
Overexpression of HSP70 attenuates sarcopenia by suppressing the expression of miR‐133b
by: Tábata L. Nascimento, et al.
Published: (2020) -
Osthole Protects against Acute Lung Injury by Suppressing NF-κB-Dependent Inflammation
by: Yiyi Jin, et al.
Published: (2018)